SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 275.75 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 69.22 |
| Book Value / Share | 1.39 |
| Price / Book | n/a |
| NCAV ($M) | 10.57 |
| NCAV / Share | 0.21 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.01 |
| Return on Assets (ROA) | 0.01 |
| Return on Equity (ROE) | 0.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.23 |
| Current Ratio | 1.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 92.77 |
| Assets | 151.42 |
| Liabilities | 82.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 70.94 |
| Operating Income | 3.28 |
| Net Income | 1.51 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 15.55 |
| Cash from Investing | -1.04 |
| Cash from Financing | -10.57 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| GLPGF – Galapagos NV | GLUC – Glucose Health, Inc. |
| GNCAQ – Genocea Biosciences, Inc. | GNMLF – Genomma Lab Internacional, S.A.B. de C.V. |
| GNMSF – Genmab A/S |
Financial data and stock pages provided by
Fintel.io